Anal adenocarcinoma: a comprehensive review

Area of Science:

• Gastroenterology and Oncology
• Pathology

Background:

• Anal adenocarcinoma is a rare malignancy, less common than other anal canal tumors.
• This cancer exhibits significant heterogeneity in histology, biology, and etiology.
• Existing knowledge gaps hinder effective cancer prevention and early detection strategies.

Purpose of the Study:

• To review the current understanding of anal adenocarcinoma, including its associations, therapeutic options, and diagnostic challenges.
• To highlight the need for further research due to the tumor's rarity and heterogeneity.

Main Methods:

• Literature review of existing studies on anal adenocarcinoma.
• Discussion of described etiologic associations (e.g., chronic fistula-in-ano, Crohn's disease).
• Analysis of therapeutic options, focusing on preoperative chemoradiation therapy.

Main Results:

• Several etiologic factors are associated with anal adenocarcinoma.
• Preoperative chemoradiation therapy shows promising results.
• The role of histology versus anatomical location in determining prognosis and treatment is unclear.

Conclusions:

• Anal adenocarcinoma is a heterogeneous and rare tumor requiring further investigation.
• Subdivision by various parameters is necessary due to its complexity.
• The impact of histology on natural history and optimal therapy allocation remains uncertain.